Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | MGAM | O43451 | 2/20 | 0.46 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ACHE | P22303 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | DHODH | Q02127 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pyridine SCHEMBL2285312 | 0.92 | ALDH1A1 (0.50) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL1131468 | 0.86 | IKBKB (0.50) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL3118854 | 0.82 | KDM4E (0.47) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL8329240 | 0.81 | ALDH1A1 (0.56) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL4602438 | 0.81 | ALDH1A1 (0.53) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL11089095 | 0.79 | KDM4E (0.50) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL31556386 | 0.79 | KDM4E (0.50) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL28026248 | 0.79 | TARBP2 (0.50) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL60874 | 0.78 | ALDH1A1 (0.61) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL70017 | 0.78 | ALDH1A1 (0.61) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 90 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0261426-B1 | FREEZE-DRIED PHARMACEUTICAL COMPOSITIONS OF PHENYLQUINOLINE CARBOXYLIC ACIDS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1992-11-04 | — | — | EP | claimed |
| US-4889862-A | BILE SALT STABILIZER FOR ANTITUMOR INJECTABLE SOLUTION | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-12-26 | — | — | US | claimed |
| EP-0261426-A1 | Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-03-30 | — | — | EP | claimed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | claimed |
| US-11495755-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-08 | — | — | US | disclosed |
| EP-3719099-A1 | PHOSPHORESCENT MATERIALS | Universal Display Corporation (US) | 2020-10-07 | — | — | EP | disclosed |
| CN-111632100-A | Traditional Chinese medicine oral liquid for treating goose gout and preparation method thereof | 安徽亿牧生物科技有限公司 | 2020-09-08 | — | — | CN | disclosed |
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-06-04 | — | — | US | disclosed |
| EP-3327100-B1 | PHOSPHORESCENT MATERIALS | UNIVERSAL DISPLAY CORP (US) | 2020-05-06 | — | — | EP | disclosed |
| US-10600975-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2020-03-24 | — | — | US | disclosed |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2019-05-23 | — | — | US | disclosed |
| US-10230060-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-03-12 | — | — | US | disclosed |
| EP-0261426-A1 | Freeze-dried pharmaceutical compositions of phenylquinoline carboxylic acids | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1988-03-30 | — | — | EP | disclosed |
| US-4680299-A | ANTITUMOR AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4680299-A | ANTITUMOR AGENTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-07-14 | — | — | US | disclosed |
| US-4639454-A | LYMPHOID LEUKEMIA | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-01-27 | — | — | US | disclosed |
| EP-0036145-B1 | AN ORALLY ADMINISTERED DRUG FORM COMPRISING A POLAR BIOACTIVE AGENT AND AN ADJUVANT | INTERx RESEARCH CORPORATION (US) | 1985-05-29 | — | — | EP | disclosed |
| EP-0133244-A2 | Phenylquinolinecarboxylic acids and derivatives as antitumor agents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-02-20 | — | — | EP | disclosed |
| EP-0133244-A2 | Phenylquinolinecarboxylic acids and derivatives as antitumor agents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-02-20 | — | — | EP | disclosed |
| EP-0133244-A2 | Phenylquinolinecarboxylic acids and derivatives as antitumor agents | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1985-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200176693-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | RUVBL2, TERT, OR10J3 | ALDH1A1 1888/4885KDM4E 3403/4885MEN1 993/4885 |
| US-11495755-B2 | Organic electroluminescent materials and devices | RUVBL2, TERT, OR10J3 | ALDH1A1 1888/4885KDM4E 3403/4885MEN1 993/4885 |
| US-10230060-B2 | Organic electroluminescent materials and devices | RUVBL2, OR10J3, EML4 | ALDH1A1 734/4885KDM4E 3060/4885MEN1 2129/4885 |
| US-10600975-B2 | Organic electroluminescent materials and devices | TERT, OR10J3, RUVBL2 | ALDH1A1 1294/4885KDM4E 3344/4885MEN1 947/4885 |
| US-20190157576-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | PIEZO1, ORAI2, PORCN | ALDH1A1 3140/4885KDM4E 3726/4885MEN1 540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.